S&P 500

5.304,72

0,70%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Dermata Therapeutics Inc (DRMA)
Dermata Therapeutics Inc (DRMA) Notícias

DRMA

Dermata Therapeutics (DRMA)

Dermata Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:DRMA

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
12/01/2024	18:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DRMA	Dermata Therapeutics Inc
05/01/2024	23:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DRMA	Dermata Therapeutics Inc
18/12/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:DRMA	Dermata Therapeutics Inc
15/12/2023	19:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:DRMA	Dermata Therapeutics Inc
08/12/2023	19:29	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:DRMA	Dermata Therapeutics Inc
07/12/2023	18:05	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:DRMA	Dermata Therapeutics Inc
29/11/2023	19:16	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:DRMA	Dermata Therapeutics Inc
09/11/2023	18:09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DRMA	Dermata Therapeutics Inc
14/09/2023	17:32	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DRMA	Dermata Therapeutics Inc
27/07/2023	17:50	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:DRMA	Dermata Therapeutics Inc
12/07/2023	10:02	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:DRMA	Dermata Therapeutics Inc
07/07/2023	17:21	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:DRMA	Dermata Therapeutics Inc
23/06/2023	17:29	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:DRMA	Dermata Therapeutics Inc
23/06/2023	17:19	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:DRMA	Dermata Therapeutics Inc
12/06/2023	18:28	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:DRMA	Dermata Therapeutics Inc
24/05/2023	18:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DRMA	Dermata Therapeutics Inc
11/05/2023	17:08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DRMA	Dermata Therapeutics Inc
31/03/2023	17:11	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DRMA	Dermata Therapeutics Inc
21/03/2023	07:01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:DRMA	Dermata Therapeutics Inc
20/03/2023	10:01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:DRMA	Dermata Therapeutics Inc
17/03/2023	07:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DRMA	Dermata Therapeutics Inc
13/03/2023	18:08	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:DRMA	Dermata Therapeutics Inc
21/02/2023	18:10	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:DRMA	Dermata Therapeutics Inc
05/01/2023	18:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DRMA	Dermata Therapeutics Inc
17/11/2022	09:25	TipRanks	Maxim Group Reaffirms Their Buy Rating on Dermata Therapeutics (DRMA)	NASDAQ:DRMA	Dermata Therapeutics Inc
16/11/2022	15:15	AllPennyStocks.com	Micro Cap Files For $100 Million Shelf Registration	NASDAQ:DRMA	Dermata Therapeutics Inc
15/11/2022	18:07	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:DRMA	Dermata Therapeutics Inc
19/08/2022	15:25	TipRanks	Maxim Group Sticks to Its Buy Rating for Dermata Therapeutics (DRMA)	NASDAQ:DRMA	Dermata Therapeutics Inc
20/05/2022	17:06	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:DRMA	Dermata Therapeutics Inc
18/05/2022	16:05	TipRanks	Dermata Therapeutics (DRMA) Has a New Rating from Maxim Group	NASDAQ:DRMA	Dermata Therapeutics Inc